1 Min Read
Feb 24 (Reuters) - Luye Pharma Group Ltd
* Obtained approval from China Food and Drug Administration to commence development of Buprenorphine Transdermal patches in prc Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.